MedTrace Logo

Prevalence Study of Depression in Chinese Patients With Type 2 Diabetes (HK13)

NCT01277432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3218

Last updated 2015-08-24

No results posted yet for this study

Summary

The investigators aim to:

1. Estimate the prevalence of depression in a consecutive cohort of Chinese patients diagnosed with Type 2 Diabetes (T2D) living in areas of China with different socioeconomical affluence
2. Examine patients' awareness of the frequent coexistence of these 2 conditions
3. Analyze the associations between depression and T2D, in particularly the role of metabolic control, socioeconomical status and cognitive-psychological-behavioral factors
4. To document the predisposing, precipitating and perpetuating factors for depression and their interrelationships in Chinese type 2 diabetic patients

Conditions

Interventions

OTHER

Psychiatrist Interview

Patients will receive a face-to-face interview by a trained clinician or psychiatrist using the following instruments: * MINI * SSI-28 (somatization)

OTHER

Depression screening - control

All study participants will undergo; 1. a comprehensive diabetes assessment by completing a full set of questionnaires and clinical assessments, using the JADE e-portal 2. a detailed psychological and behavioral assessments using validated questionnaires 3. several specialist questionnaires on depression, self care and quality of life

Sponsors & Collaborators

  • Asia Diabetes Foundation

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Juliana Chan, MD · Chinese University of Hong Kong

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • China
  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01277432 on ClinicalTrials.gov